Human intestinal mucosal cell

Human intestinal mucosal cells constitute the epithelial lining of the gastrointestinal tract, serving as the primary site for nutrient absorption and a critical barrier against luminal pathogens (NIH, 2023). This heterogeneous population includes enterocytes, goblet cells, and enteroendocrine cells, which collectively maintain intestinal homeostasis through secretion, absorption, and immune signaling (StatPearls, 2023). Dysfunction of these cells is a hallmark of diseases such as Crohn's disease, ulcerative colitis, and celiac disease, where the integrity of the mucosal barrier is compromised (PubMed, 2022). While the cells themselves are a tissue-level entity rather than a single molecular target, they express a wide array of therapeutic targets, including ion transporters, G protein-coupled receptors, and cytokine receptors (Nature Reviews Gastroenterology & Hepatology, 2021). Drugs like linaclotide and mesalamine act locally on these cells to treat functional and inflammatory disorders, respectively (PubChem, 2023). Consequently, these cells are central to the study of gastrointestinal pharmacology and the development of mucosal healing agents.

Other names

Intestinal epithelial cellEnterocyteGut mucosal cellIntestinal mucosaIntestinal lining cell

Pharmacological agents interact with specific molecular components within these cells, such as guanylate cyclase-C (GC-C) to stimulate fluid secretion, or various transporters and receptors to modulate nutrient uptake and local inflammatory signaling (StatPearls, 2023; PubChem, 2023).